Lv2
196 积分 2023-02-20 加入
E-cadherin: A potential biomarker in cancer and a therapeutic target
4个月前
已完结
Recent Progress and Prospects of Small Molecules for NLRP3 Inflammasome Inhibition
6个月前
已完结
Targeting the NLRP3 inflammasome in inflammatory diseases
6个月前
已完结
Ofirnoflast: a first-in-class NEK7-targeted inhibitor of the NLRP3 inflammasome
7个月前
已完结
Innovative antibody therapeutic development in China compared with the USA and Europe
8个月前
已完结
Trastuzumab rezetecan, a HER2-directed antibody–drug conjugate, in patients with advanced HER2-mutant non-small-cell lung cancer (HORIZON-Lung): phase 2 results from a multicentre, single-arm study
8个月前
已完结
Novel Controlled Metabolic Accelerator for Obesity-Related HFpEF
8个月前
已完结
Safety and efficacy of once-daily HU6 versus placebo in people with non-alcoholic fatty liver disease and high BMI: a randomised, double-blind, placebo-controlled, phase 2a trial
8个月前
已完结
ErbB Receptors and Cancer
11个月前
已完结
[Clinical pathway for diagnosis and management of endometrial polyps]
1年前
已完结
皖公网安备34019202002308
